Options for bronchodilation in children: Can we rely on adult data?

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 54, Issue 49, 1999, Pages 51-54

  Verberne, A A P H ^a,b  

^a Department of Pediatrics ^*  (Netherlands)

^b Ignatius Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FORMOTEROL; IPRATROPIUM BROMIDE; SALMETEROL; THEOPHYLLINE DERIVATIVE;

ADULT; ASTHMA; BRONCHODILATATION; BRONCHODILATING ACTIVITY; CHILD; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; ADULT; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; CHOLINERGIC ANTAGONISTS; DATA INTERPRETATION, STATISTICAL; HUMANS; REPRODUCIBILITY OF RESULTS; THEOPHYLLINE;

EID: 0033006107     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. Publication no. 95-3695. National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda, MD, 1995.
2. Warner JO, Naspitz CK. Third international pediatric consensus statement on the management of childhood asthma. Pediatr Pulmonol 1998;25:1-17.
3. Nelson HS. Beta-adrenergic bronchodilators. N Engl J Med 1995;333:4999-4505.
4. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
5. Crane J, Pearce N, Flatt A, et al. Case control study of prescribed fenoterol and death from asthma in New Zealand, 1981-3; case-control study. Lancet 1989;i:917-922.
6. Pearce N, Grainger J, Atkinson M, et al. Case control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax 1990;45:170-175.
7. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-506.
8. Lenney W, Wells NEJ, O'Neill BA. The burden of paediatric asthma. Eur Respir Rev 1994;4:49-62.
9. Scars MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391-1396.
10. van Schayck CP, Dompeling E, van Herwaarden CLA, et al. Bronchodilator treatment in moderate asthma or chronic bronchitis; continuous or on demand? A randomized controlled study. BMJ 1991;303:1426-1431.
11. van Essen-Zandvliet EEM, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF, Dutch CNSLD Study Group. Effects of 22 months' treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 1992;146;547-554.
12. Vathenen AS, Knox AJ, Higgins BG, Britton JR, Tattersfield AE. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988;i:554-558.
13. Weber RW. Role of anticholinergics in asthma. Ann Allergy 1990;65:348-350.
14. Schuh S, Johnson DW, Callahan S, Canny G, Levison H. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr 1995;126:639-645.
15. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993;92:64-77.
16. Aubier M, Barnes PJ. Theophylline and phosphodiesterase inhibitors. Eur Respir J 1995;8:347-348.
17. Verberne AAPH, De Jongste JC. The role of inhaled long-acting bronchodilator therapy. Eur Respir Rev 1996;6:199-203.
18. Britton MG, Earnshaw JS, Palmer JBD. Twelve month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992;5:1062-1067.
19. Lenney W, Pedersen S, Boner AC, Ebbutt A, Jenkins MM. Efficacy and safety of salmeterol in childhood asthma. Eur J Paediatr 1995;154:983-990.
20. van der Molen T, Postma DS, Turner MO, et al. The Netherlands and Canadian formoterol study investigators. Thorax 1997;52:535-539.
21. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-224.
22. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroid with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488.
23. Pauwels R, Löfdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-1411.
24. Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walters EH. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med 1994;150:1006-1011.
25. Verberne AAPH, Frost C, Roorda RJ, van der Laag H, Kerrebijn KF, Dutch Paediatric Asthma Study Group. One year treatment with salmeterol compared with beclomethasone in children with asthma. Am J Respir Crit Care Med 1997;156:688-695.
26. Simons FER, Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. N Engl J Med 1997;337:1659-1665.
27. Verberne AAPH, Frost C, Duivermati EJ, Grol MH, Dutch Paediatric Asthma Study Group. Addition of salmeterol versus doubling the dose of beclotmethasone in children with asthma. Am J Respir Crit Care Med 1998;158:213-219.
28. Redington AE, Howarth PH. Airway wall remodeling in asthma. Thorax 1997;51:310-312.
29. Haahtela T, Järvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-705.
30. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-381.